World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
41
Citations
5921
World Ranking
7912
National Ranking
3401

Michael Bubser publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Michael Bubser sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 100 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Michael Bubser D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Bubser sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 41 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Michael Bubser is affiliated with Vanderbilt University in the United States and conducts research primarily in the fields of Biochemistry, Genetics and Molecular Biology, as well as Neuroscience. Their work focuses on molecular biology and cellular and molecular neuroscience within these broader disciplines, with additional interests in cognitive neuroscience, endocrine and autonomic systems, and pharmacology.

The main topics that define Bubser's research include receptor mechanisms and signaling, neuroscience and neuropharmacology research, and nicotinic acetylcholine receptors study. They have also contributed to understanding neurotransmitter receptor influence on behavior, memory and neural mechanisms, pharmacological receptor mechanisms and effects, and circadian rhythm and melatonin.

They have published notably in several venues with multiple papers in the following journals:

  • Journal of Medicinal Chemistry
  • ACS Chemical Neuroscience
  • Alzheimer's & Dementia
  • Neuropsychopharmacology
  • Neuropharmacology

Frequent collaborators of Michael Bubser include Craig W. Lindsley, Carrie K. Jones, P. Jeffrey Conn, Sichen Chang, and Olivier Boutaud.

Their recent scientific articles demonstrate a focus on muscarinic acetylcholine receptor pharmacology and neuropharmacological approaches to opioid use disorder and neural modulation. Selected recent papers are:

  • Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder, 2022, Journal of Medicinal Chemistry
  • Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates, 2020, Neuropsychopharmacology
  • Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration, 2023, Neuropharmacology
  • Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor, 2024, Journal of Medicinal Chemistry
  • Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM), 2024, ACS Chemical Neuroscience

Best Publications

  • 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze.

    Michael Bubser;Werner J. Schmidt

  • Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

    Carrie K. Jones;Ashley E. Brady;Albert A. Davis;Zixiu Xiang

  • Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

    Carrie K Jones;Nellie Byun;Michael Bubser

  • Differential Activation of Orexin Neurons by Antipsychotic Drugs Associated with Weight Gain

    Jim Fadel;Michael Bubser;Ariel Y. Deutch

  • Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex.

    Michael Bubser;Michael Koch

  • Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.

    Werner J. Schmidt;Michael Bubser

  • 5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex

    Walid M. Abi-Saab;Michael Bubser;Robert H. Roth;Ariel Y. Deutch

  • DOI-Induced Activation of the Cortex: Dependence on 5-HT2A Heteroceptors on Thalamocortical Glutamatergic Neurons

    Jennifer L. Scruggs;Sachin Patel;Michael Bubser;Ariel Y. Deutch

  • Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.

    Michael Bubser;Ute Keseberg;Petra K. Notz;Werner J. Schmidt

  • Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol.

    Michael Koch;Michael Bubser

  • Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites.

    Michael Bubser;Ariel Y. Deutch

  • Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

    Michael Bubser;Thomas M Bridges;Thomas M Bridges;Ditte Dencker;Robert W Gould

  • Muscarinic Receptor Pharmacology and Circuitry for the Modulation of Cognition

    Michael Bubser;Nellie Byun;Michael R. Wood;Carrie K. Jones

  • The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease

    Carrie K. Jones;Michael Bubser;Analisa D. Thompson;Jonathan W. Dickerson

  • Biased mGlu5-positive allosteric modulators provide in vivo efficacy without potentiating mGlu5 modulation of NMDAR currents

    Jerri M. Rook;Zixiu Xiang;Xiaohui Lv;Ayan Ghoshal

  • Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.

    Nellie E Byun;Michael Grannan;Michael Bubser;Robert L Barry

  • Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models

    G. J. Digby;M. J. Noetzel;M. Bubser;T. J. Utley

  • Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

    Richard M. Gustin;Terry Jo Bichell;Michael Bubser;Jennifer Daily

  • Behavioural pharmacology of glutamate in the basal ganglia.

    Werner J. Schmidt;Michael Bubser;Wolfgang Hauber

  • Dopaminergic regulation of orexin neurons.

    Michael Bubser;Jim R. Fadel;Lela L. Jackson;James H. Meador-Woodruff

Frequent Co-Authors

Carrie K. Jones
Carrie K. Jones Vanderbilt University
Craig W. Lindsley
Craig W. Lindsley Vanderbilt University
P. Jeffrey Conn
P. Jeffrey Conn Vanderbilt University
Colleen M. Niswender
Colleen M. Niswender Vanderbilt University
Ariel Y. Deutch
Ariel Y. Deutch Vanderbilt University
Werner J. Schmidt
Werner J. Schmidt University of Tübingen
Nicholas J. Brandon
Nicholas J. Brandon Neumora Therapeutics Inc
Jürgen Wess
Jürgen Wess National Institutes of Health
Wolfgang Hauber
Wolfgang Hauber University of Stuttgart
Michael Koch
Michael Koch University of Bremen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can open the door to a range of online degree options and career paths in mental health, research, and counseling. Many students consider advancing their expertise through specializations or related fields that also support neurological science and human behavior.

For those interested in clinical roles, msw programs offer accelerated routes to careers in social work, often with a behavioral health or clinical focus. Similarly, students looking to study behavior intensively may find accelerated psychology programs a flexible and efficient way to deepen their knowledge online.

Aspiring counselors or therapists can take advantage of affordable remote learning opportunities. The cheapest online counseling degree options cover foundational and advanced theory, while the most affordable online counseling degrees list makes it easier to plan for graduate education without heavy financial burdens.

Whether your goal is research, clinical practice, or counseling, these related degrees offer diverse pathways to build on a neuroscience background and prepare for in-demand roles in the mental health and wellness sectors.

Best Scientists Citing Michael Bubser

Trending Scientists

Recently Published Articles